Follow-On Biologics Guidance Will Follow Public Workshop, FDA Tells Senate
Executive Summary
FDA's draft guidance on follow-on biologics will be preceded by a scientific workshop on the topic, Acting Commissioner Lester Crawford told the Senate Judiciary Committee June 23
You may also be interested in...
FDA Follow-On Biologics Public Meeting Slated For Early ’05
FDA and the Drug Information Association are looking at dates in early 2005 for a public meeting on scientific issues surrounding the development of follow-on biologics
FDA Follow-On Biologics Public Meeting Slated For Early ’05
FDA and the Drug Information Association are looking at dates in early 2005 for a public meeting on scientific issues surrounding the development of follow-on biologics
Follow-On Biologics Will Rely On “Case-By-Case” Approach – Rep. Waxman
FDA's development of a guidance for follow-on versions of insulin and human growth hormone will be a key milestone in demonstrating the agency's ability to implement a "case-by-case" approach to "generic" biologics, Rep. Henry Waxman (D-Calif.) said